Shinsuke Mizutani

Loss of RUNX1/AML1 arginine‐methylation impairs peripheral T cell homeostasis

M. Taniwaki, Tatsushi Yoshida, S. Nimer, 2015, British journal of haematology.

Therapy‐related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients

Terukazu Nakamura, K. Okihara, O. Ukimura, 2018, International journal of urology : official journal of the Japanese Urological Association.

8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia

Taku Tsukamoto, Yosuke Matsumoto, Tsutomu Kobayashi, 2014, Journal of Hematology & Oncology.

Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma

M. Taniwaki, H. Kaneko, J. Kuroda, 2022, Leukemia & lymphoma.

Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia

M. Taniwaki, S. Horiike, J. Kuroda, 2010, International journal of hematology.

NS-018, a selective JAK2 inhibitor, preferentially inhibits CFU-GM colony formation by bone marrow mononuclear cells from high-risk myelodysplastic syndrome patients.

M. Taniwaki, J. Kuroda, Ayumi Kodama, 2014, Leukemia research.